Search research articles
Contact Us
Filters
Showing results (201-210 of 229) with videos related to
Page
of 23
Sort By:
Circulation. Heart Failure
|
May 12, 2018
Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data
Marco Metra, Gad Cotter, Stefanie Senger, et al.
Circulation. Heart Failure
|
November 28, 2013
Renal function trajectories and clinical outcomes in acute heart failure
Michael M Givertz, Douwe Postmus, Hans L Hillege, et al.
The New England Journal of Medicine
|
October 8, 2010
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
Barry M Massie, Christopher M O'Connor, Marco Metra, et al.
European Journal of Heart Failure
|
March 3, 2017
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure
Biniyam G Demissei, Douwe Postmus, John G Cleland, et al.
Circulation. Heart Failure
|
September 9, 2011
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study
Christopher M O'Connor, Mona Fiuzat, Carlo Lombardi, et al.
European Journal of Heart Failure
|
June 18, 2015
Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial
Robert J Mentz, Marco Metra, Gad Cotter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme
M J van den Bent, W Grisold, D Frappaz, et al.
Journal of Cardiac Failure
|
November 11, 2008
Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF)
Larry A Allen, Marco Metra, Olga Milo-Cotter, et al.
International Journal of Cardiology
|
September 3, 2016
Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial
Biniyam G Demissei, Douwe Postmus, Licette C Y Liu, et al.
European Journal of Heart Failure
|
November 22, 2013
Sex-specific acute heart failure phenotypes and outcomes from PROTECT
Sven Meyer, Peter van der Meer, Barry M Massie, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 229) with videos related to
Sort By:
Page
of 23
Circulation. Heart Failure
|
May 12, 2018
Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data
Marco Metra, Gad Cotter, Stefanie Senger, et al.
Circulation. Heart Failure
|
November 28, 2013
Renal function trajectories and clinical outcomes in acute heart failure
Michael M Givertz, Douwe Postmus, Hans L Hillege, et al.
The New England Journal of Medicine
|
October 8, 2010
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
Barry M Massie, Christopher M O'Connor, Marco Metra, et al.
European Journal of Heart Failure
|
March 3, 2017
Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure
Biniyam G Demissei, Douwe Postmus, John G Cleland, et al.
Circulation. Heart Failure
|
September 9, 2011
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study
Christopher M O'Connor, Mona Fiuzat, Carlo Lombardi, et al.
European Journal of Heart Failure
|
June 18, 2015
Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial
Robert J Mentz, Marco Metra, Gad Cotter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme
M J van den Bent, W Grisold, D Frappaz, et al.
Journal of Cardiac Failure
|
November 11, 2008
Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF)
Larry A Allen, Marco Metra, Olga Milo-Cotter, et al.
International Journal of Cardiology
|
September 3, 2016
Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial
Biniyam G Demissei, Douwe Postmus, Licette C Y Liu, et al.
European Journal of Heart Failure
|
November 22, 2013
Sex-specific acute heart failure phenotypes and outcomes from PROTECT
Sven Meyer, Peter van der Meer, Barry M Massie, et al.
Page
of 23